">

Applied Biosystems Solutions for Cancer Research

Applied Biosystems solutions have the answers to big oncology questions

What if we could prevent tumor formation? Detect cancer without invasive biopsies? Or cure even the most aggressive cancers? For those willing to ask the big questions in cancer research, Applied Biosystems solutions are where the answers come together. We deliver the accuracy, speed, and breadth of solutions you need to facilitate your oncology research from discovery through delivery of life-changing treatments.

Understanding cancer and neurodegeneration with genetic biomarkers eBook

We are entering the era of precision medicine, with the goal to optimize the effectiveness and safety of therapies by matching the treatment to the biology for which the treatment was designed. Much work has been done to identify measurable molecular characteristics that can be used for the diagnosis, prognosis, and safety of treatments that provide minimal discomfort to the patient but maximize the chance of success.

 

Download our latest eBook to learn about the significance of DNA and RNA biomarkers in cancer and neurodegeneration and how genetic analysis technologies can support research in these areas.
 

Understanding cancer with precision genomics

Applied Biosystems solutions include a comprehensive range of tools that are extensively utilized in cancer research. In this eBook, learn how genomics can be incorporated into cancer research, from decoding cancer signatures from extracellular vesicles to using circulating tumor DNA to predict survival rates.
 

Advancing cancer research using genetic analysis tools

New advances in gold-standard genetic technologies such as qPCR, CE sequencing, and microarrays continue to drive fundamental and applied discoveries in oncology. More recent technologies such as NGS, microfluidic dPCR, and others are enabling researchers to pursue new territory with greater sensitivity, precision, and speed. This eBook explores how genetic technologies have enabled some of the most recent and exciting discoveries in several areas of cancer research. 
 

Customer spotlights

Olga Vera

Junior Principal Investigator, Epigenetics Laboratory
La Paz University Hospital

Olga Vera uses both digital and qPCR technologies to explore non-genetic alterations in melanoma.

Atocha Romero

Director, Liquid Biopsy Laboratory
Hospital Universitario Puerta di Hierro


Dr. Romero and her team hope to utilize digital PCR technology to eventually develop effective screening for lung cancer.
 

Tata Medical Team

Tata Medical Center
Kolkata


Dr. Col. Deepak Mishra and his team of researchers share how Applied Biosystems technologies enable their research on acute leukemias.

Francis Barany

Professor, Microbiology
Weill Cornell Medicine

Dr. Barany discusses his research into new liquid biopsy methods that use cost-efficient and scalable technology, in order to make cancer detection more accessible.

Kristi Baker

Associate Professor
University of Alberta

Dr. Kristi Baker shares how her lab uses both animal and human models for their research into colon cancer, in order to close the gap between bench and bedside.

Sheri Olson

Vice President and General Manager
Human Identification
Thermo Fisher Scientific

Meet Sheri Olson and learn about her journey from a curious kid to one of the history-making scientists who studied and patented the BRCA 1 breast cancer gene.
 

Lanbo Xiao

Research Investigator
Michigan Center for Translational Pathology
University of Michigan

Meet Lanbo Xiao, a researcher using TaqMan Gene Expression assays to differentiate between aggressive and non-aggressive prostate cancer.
 

Derek McMahon

Postdoctoral Fellow
University of Pennsylvania


Derek McMahon, PhD, explains how bitter compounds, such as quinine, have the potential to act as therapies for multiple diseases, including cancer.
 

Featured blog posts

DNA & RNA biomarkers

Advances in analytical technologies to discover and probe nucleic acid biomarkers can potentially enable us to overcome many challenges in cancer research.

Advances in lung cancer & glioblastoma research

We spoke to two experts in the field of liquid biopsy to learn more about the potential of circulating tumor DNA in monitoring lung cancer and glioblastoma.

Liquid biopsy and cancer

Cancer researchers like Dr. Atocha Romero are allowing us to determine potentially effective use of liquid biopsy in cancer diagnosis and management. We spoke with her to learn more about the challenges and opportunities involved in this approach.

Related pages

QuantStudio Absolute Q Digital PCR System

SeqStudio Flex Genetic Analyzers

For Research Use Only. Not for use in diagnostic procedures.

">